These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6465620)

  • 21. [Effect of papaverine and trental on hemostasis and rheologic properties of blood in acute arterial obstruction].
    Zatevakhin II; Koshkin VM; Shestakov VA; Il'in SG; Adil'khanov SG
    Probl Gematol Pereliv Krovi; 1979 Dec; 24(12):40-3. PubMed ID: 523450
    [No Abstract]   [Full Text] [Related]  

  • 22. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
    Billett HH; Kaul DK; Connel MM; Fabry ME; Nagel RL
    Nouv Rev Fr Hematol (1978); 1989; 31(6):403-7. PubMed ID: 2694097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemorheology and peripheral vascular diseases: a new therapeutic approach.
    Müller R
    J Med; 1981; 12(4):209-35. PubMed ID: 7031157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the effect of pentoxifylline in ischemic heart disease.
    Kobaladze SG
    Verh Dtsch Ges Inn Med; 1978; (84):728-32. PubMed ID: 742110
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of furosemide and pentoxifylline on blood flow properties in horses.
    Geor RJ; Weiss DJ; Burris SM; Smith CM
    Am J Vet Res; 1992 Nov; 53(11):2043-9. PubMed ID: 1466500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of hexobendine and pentoxifylline on the viscosity of erythrocyte suspension].
    Winkler R; Moser M
    Wien Klin Wochenschr; 1983 Mar; 95(6):209-13. PubMed ID: 6880203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new method of measuring red cell deformability and the effects of pentoxifylline.
    Isogai Y; Mochizuki K; Ashikaga M
    Curr Med Res Opin; 1981; 7(6):352-8. PubMed ID: 7238085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelioration of blood viscosity in sickle cell anemia by pentoxifylline. A case report.
    Keller F; Leonhardt H
    J Med; 1979; 10(6):429-33. PubMed ID: 299452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentoxifylline -- a biomedical profile.
    Müller R
    J Med; 1979; 10(5):307-29. PubMed ID: 393789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.
    Dettelbach HR; Aviado DM
    J Clin Pharmacol; 1985; 25(1):8-26. PubMed ID: 3882773
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemocoagulation, fibrinolytic and rheologic parameters in ischemic vasculopathy. Effects of pentoxifylline in the treatment of acute cerebral vasculopathy].
    Muggeo M; Calabrò A; Businaro V; Patussi L; Volpe A; Signorini GP; Crepaldi G
    Ric Clin Lab; 1981; 11 Suppl 1():353-71. PubMed ID: 7188124
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes and relationships of erythrocyte flexibility and whole blood viscosity of normo-osmolar and hyperosmolar erythrocyte suspensions influenced by 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
    Leonhardt H; Grigoleit HG; Reinhardt I
    Vasa; 1977; 6(4):316-20. PubMed ID: 930285
    [No Abstract]   [Full Text] [Related]  

  • 33. The BMRES 1984 Medical Research Expedition to the Himalayas.
    Bradwell AR; Coote JH
    Postgrad Med J; 1987 Mar; 63(737):165-7. PubMed ID: 3671253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration.
    Parnetti L; Ciuffetti G; Mercuri M; Lupattelli G; Senin U
    Pharmatherapeutica; 1986; 4(10):617-27. PubMed ID: 3602014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
    Runge E; Thiele P
    Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional vascular disorders: treatment with pentoxifylline.
    Neirotti M; Longo F; Molaschi M; Macchione C; Pernigotti L
    Angiology; 1987 Aug; 38(8):575-80. PubMed ID: 3631642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rheologic effect of naftidrofuryl and pentoxifylline].
    Radtke H; Kiesewetter H; Roggenkamp HG; Jung F
    Med Welt; 1983 Jul; 34(29-30):833-6. PubMed ID: 6621333
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sudden deafness: apropos of 19 cases. Results of treatment with pentoxifylline. Value of erythrocyte filtration time].
    Denis F; Ketari M; Benzaken J; Renou G
    Ann Otolaryngol Chir Cervicofac; 1989; 106(1):21-6. PubMed ID: 2719437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Medical experiences from the Norwegian Nanga Parbat Expedition 1990].
    Rostrup M
    Tidsskr Nor Laegeforen; 1991 Mar; 111(8):929-34. PubMed ID: 2042206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythrocyte deformability in a red cell ageing model.
    Leonhardt H; Grigoleit HG; Reinhardt I
    Ric Clin Lab; 1978; 8(1-2):65-71. PubMed ID: 705180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.